Thursday 03 Jul, 2025 07:03 AM
Site map | Locate Us | Login
   Bharat Forge gains after acquiring AAM India manufacturing    NBCC (India) secures Rs 355 crore PMC contract for Gorewada Zoo Project    Jindal Worldwide Ltd leads losers in 'A' group    Sigachi Industries Ltd leads losers in 'B' group    Volumes spurt at Rites Ltd counter    Dr Reddys Laboratories Ltd slips for fifth straight session    Oracle Financial Services Software Ltd eases for fifth straight session    United Spirits Ltd down for fifth straight session    Dev IT gains on securing Rs 4-cr orders from Alivus Lifesciences    Glenmark Pharmaceuticals Ltd up for third straight session    Steel Authority of India Ltd up for third straight session    Jindal Steel & Power Ltd soars 1.67%, rises for third straight session    Lupin gets USFDA nod for Loteprednol Etabonate Ophthalmic Gel    Tamilnad Mercantile Bank total deposits jump 9% YoY to Rs 53,803 cr in June'25    Spandana Sphoorty declines after Crisil Ratings downgrades ratings to 'BBB+' 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
AstraZeneca Pharma gets CDSCO approval to import Durvalumab Solution
02-Jul-25   10:26 Hrs IST

Through this approval, Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy, followed by maintenance treatment with Durvalumab in combination with olaparib in endometrial cancer that is mismatch repair proficient (pMMR).

AstraZeneca Pharma is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory and Rare Disease.

The company's consolidated net profit jumped 57.7% to Rs 62.27 crore on 25.4% increase in net sales to Rs 480.48 crore in Q4 FY25 over Q4 FY24.

The scrip shed 0.13% to Rs 8,886.50 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 42372391
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited